|Bid||72.00 x 1200|
|Ask||76.01 x 900|
|Day's Range||70.33 - 76.98|
|52 Week Range||56.51 - 232.76|
|Beta (5Y Monthly)||0.84|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies (“AeroClean” or the “Company”) (Nasdaq: AERC), a pathogen elimination technology company harnessing patented UV-C LED technology with Pūrgo™ to significantly reduce and remove harmful pathogens to keep work, play and life going, today announced the appointment of Timothy J. Scannell, former President and Chief Operating Officer at Stryker, to its Board of Directors (the “Board”). On May 11, 2022, the Board appointe
ST. HELIER, Jersey, April 28, 2022--Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended March 31, 2022. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields (TTFields).
ST. HELIER, Jersey, April 19, 2022--Novocure hosted a ceremonial groundbreaking with New Hampshire Governor Chris Sununu at Novocure's new flagship facility in Portsmouth, NH.